SL Meditech CO.

SL Meditech CO., a South Korea-based sole proprietorship, supplies hematology reagents, coagulation analyzers, and related consumables to the Defense Health Agency as a prime contractor, serving U.S. military medical facilities in South Korea on full-and-open competitive purchase orders with no set-aside designation. The vendor operates exclusively as a prime and holds the exclusive distribution right for Sysmex analyzer equipment and reagents in the region, a position that has justified sole-source procurement authority in at least one recent award.

SL Meditech's entire four-award footprint concentrates with a single customer: the Defense Health Agency, which accounts for 100% of awards and combined potential value ($2.3 million). The vendor supplies the 51st Medical Group at Osan Air Base, the Brian D. Allgood Army Community Hospital, and four additional clinics across South Korea. Recent representative work includes a $1.17 million purchase order (awarded August 1, 2023, through September 30, 2027) for hematology reagents and analyzers across BDAACH and four other clinics in Korea; a $603,600 purchase order (awarded October 1, 2026, through September 30, 2031) for Sysmex equipment installation, implementation, reagents, consumables, and technical support at Osan Air Base; and two additional $252,870 and $258,020 orders for hematology reagents and analyzer equipment (awarded September and November 2023 respectively, completing through 2026–2028).

Activity is sparse and recent. Three awards were placed in 2023; one was placed in October 2026 (two weeks ago). Combined dollars obligated stand at $1.3 million (55% of combined potential value), indicating partial draw-down on awarded ceilings. Two awards carrying combined potential value of $1.4 million face ultimate completion within the next twenty-four months and therefore stand for recompete. The vendor holds no seats on GWACs, BPAs, or agency-wide IDIQs; all four awards are direct purchase orders issued by the Defense Health Agency.